KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Gsk (GSK) Total Current Liabilities (2016 - 2025)

Historic Total Current Liabilities for Gsk (GSK) over the last 17 years, with Q3 2025 value amounting to -$28.8 billion.

  • Gsk's Total Current Liabilities fell 322.4% to -$28.8 billion in Q3 2025 from the same period last year, while for Sep 2025 it was -$28.8 billion, marking a year-over-year decrease of 322.4%. This contributed to the annual value of -$27.7 billion for FY2024, which is 20583.81% down from last year.
  • According to the latest figures from Q3 2025, Gsk's Total Current Liabilities is -$28.8 billion, which was down 322.4% from -$27.2 billion recorded in Q2 2025.
  • Gsk's Total Current Liabilities' 5-year high stood at $31.9 billion during Q4 2021, with a 5-year trough of -$47.6 billion in Q2 2022.
  • For the 5-year period, Gsk's Total Current Liabilities averaged around -$18.6 billion, with its median value being -$27.2 billion (2025).
  • In the last 5 years, Gsk's Total Current Liabilities skyrocketed by 7587.75% in 2022 and then tumbled by 27301.22% in 2023.
  • Quarter analysis of 5 years shows Gsk's Total Current Liabilities stood at $31.9 billion in 2021, then decreased by 16.15% to $26.8 billion in 2022, then decreased by 2.26% to $26.1 billion in 2023, then tumbled by 206.5% to -$27.8 billion in 2024, then fell by 3.35% to -$28.8 billion in 2025.
  • Its Total Current Liabilities stands at -$28.8 billion for Q3 2025, versus -$27.2 billion for Q2 2025 and -$26.2 billion for Q1 2025.